Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-23 3:52 pm Unchanged | 2023-01-23 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 12:22 pm Unchanged | 2022-02-11 | 13G | Nektar Therapeutics NKTR | Invesco Ltd. IVZ | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 12:26 pm Unchanged | 2022-02-10 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-09 09:22 am Unchanged | 2022-02-09 | 13G | Nektar Therapeutics NKTR | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-04 09:29 am Unchanged | 2022-02-04 | 13G | Nektar Therapeutics NKTR | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-27 1:59 pm Unchanged | 2022-01-27 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-25 6:45 pm Unchanged | 2022-01-25 | 13G | Nektar Therapeutics NKTR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-10 11:49 am Unchanged | 2022-01-10 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-12-10 08:52 am Unchanged | 2021-12-10 | 13G | Nektar Therapeutics NKTR | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |